Review of peptide growth factors in benign prostatic hyperplasia and urological malignancy.
Steiner
M S
MS
Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee 37232-2765.
D000818:Animals; D004815:Epidermal Growth Factor / Q000502:physiology; D005346:Fibroblast Growth Factors / Q000502:physiology; D006133:Growth Substances / Q000502:physiology*; D006801:Humans; D007680:Kidney Neoplasms / Q000503:physiopathology; D008297:Male; D011470:Prostatic Hyperplasia / Q000503:physiopathology*; D011471:Prostatic Neoplasms / Q000503:physiopathology; D013002:Somatomedins / Q000502:physiology; D016212:Transforming Growth Factor beta / Q000502:physiology; D001749:Urinary Bladder Neoplasms / Q000503:physiopathology; D014565:Urogenital Neoplasms / Q000503:physiopathology*
D006133:Growth Substances; D013002:Somatomedins; D016212:Transforming Growth Factor beta; D005346:Fibroblast Growth Factors; D004815:Epidermal Growth Factor